JIMSMENews

Follow us : Mail

Revenue shrinks at Vaishali Pharma


Vaishali Pharma announced Board of Directors approved audited financial result for the six months and year end on 31st March, 2019.

Company : Vera Synthetic Limited

published the standalone financial result of the company for the year that ended on 31st March, 2019. The revenue of the company stood at Rs.7707.33 Lac on the year that ended on 31st March, 2019.


Vaishali Pharma Ltd earned revenue of Rs.2067.70 Lac by the six months that ended on 30th September, 2018 and Rs.5639.63 Lac by the quarter that ended on 31st March, 2019. The company achieved revenue of Rs.4554.08 Lac in the same quarter, previous year. The company achieved Rs.1085.55 Lac more revenue by the end of 31st March 2019 quarter as compared to the same quarter of 2018.


The revenue of the company was Rs.7707.33 Lac by the end of 31.3.2019 and Rs.6942.30 Lac by the end of 31.3.2018. The company achieved Rs.765.03 Lac more revenue by the year end of 31st March 2018 as compared to the end of 2019 financial year.


As per the report published by Vaishali Pharma Ltd, the company has made a before tax profit of Rs.42.85 Lac by 30.9.2018 and Rs.70.40 Lac by the end of 31st March, 2019 quarter. The company made a before tax profit of Rs.113.25 Lac by 31st March, 2019 and profit of Rs.134.55 Lac was made by 31st March, 2018. The before tax profit saw a decrease Rs.21.3 Lac at the end of 2019 as compared to the financial year of 2018.


The company made a net profit of Rs.40.29 Lac by the half year that ended on 31.3.2019. The net profit of the company stood at Rs.71.36 Lac on 31.3.2019 as compared to Rs.79.76 Lac by the end of 31st March, 2018. Net profit decreased of Rs.8.4 Lac in financial year of 2019.


Recent Stories

Weekly Journal

Get weekly updates on latest SME news in your e-mail.


Weekly Journal
Get weekly updates on latest SME news in your e-mail.
Terms of Use |Privacy Policy
Copyright © 2019 JimSMEnews. The JimSMEnews is not responsible for the content of external sites. Read about our approach to external linking.